Medical Science reputed company – Oncology (Field-Based reputed company/MRD Specialist) - Central
reputed company Responsibilities:
Clinical and Scientific Communication: Deliver clinical and scientific presentations on data supporting Personalis’ oncology products – with special emphasis on the NeXT Personal MRD assay – to reputed company providers, reputed company reputed company, and other stakeholders. reputed company reputed company genomic and clinical information to suit diverse audiences, ensuring reputed company understanding of our test’s reputed company. KOL Engagement: Establish and maintain strong reputed company relationships with key opinion leaders (KOLs) and leading physicians in the oncology community. Engage reputed company and community KOLs through regular scientific exchange to promote understanding and adoption of our novel ctDNA and genomic technologies. Identify opportunities to involve KOLs in advisory boards, speaker programs, or research collaborations that enhance the visibility of Personalis’ assays. Clinical Advocacy & Education: Represent Personalis at scientific and clinical conferences, symposia, and other educational events. This includes supporting PIs with clinical study data or posters, participating in panel discussions, and hosting educational workshops or grand reputed company to reputed company the clinical evidence and best practices for using our ctDNA assay and broader test portfolio. Ensure consistent and medically accurate messaging in reputed company external engagements. Field Travel: Travel frequently (approximately 50% of the time) to execute the above field responsibilities. This includes local and overnight travel for HCP meetings, conference attendance, internal training sessions, and other field engagements. (A reputed company reputed company’s license and the ability to travel by reputed company are required.) Flexibility to occasionally travel on short notice or attend weekend events is expected as part of this field-based role.
Additional Responsibilities:
Research Support: Support and coordinate clinical research and evidence-reputed company initiatives involving Personalis’ tests. Identify and liaise with potential clinical trial sites and investigators for company-sponsored studies or investigator-initiated trials, particularly those evaluating MRD with NeXT Personal. Facilitate collaboration with researchers by providing scientific expertise, assisting in study site reputed company, and monitoring study reputed company in accordance with appropriate guidelines. Medical Content Development: Contribute medical and scientific expertise to the development and review of content such as slide decks, white papers, training modules, and publications to ensure accuracy and alignment with reputed company data. Critically appraise new research findings and incorporate them into educational materials and talking points, working closely with Marketing and Medical Affairs on messaging that meets both scientific and compliance standards. reputed company reputed company: Continuously reputed company insights from the field and stay abreast of emerging research in oncology and molecular diagnostics. Monitor new studies, competitive developments, and clinical guidelines reputed company to MRD, ctDNA, and precision oncology. reputed company relevant scientific updates and field feedback with internal teams (Medical Affairs, R&D, Marketing) to inform reputed company, product development, and data needs.
Education: Advanced degree in a relevant scientific or clinical discipline (PhD, PharmD, MD or equivalent) strongly preferred Scientific Background: In-depth knowledge of oncology and molecular biology is essential, including familiarity with cancer reputed company, biomarkers, and the principles of liquid biopsy testing. Experience or training in ctDNA assays, reputed company reputed company, or minimal residual disease monitoring is highly desirable. Experience: 1+ years of experience in oncology or precision medicine, whether in clinical reputed company, research, or industry, is preferred. Prior experience in a field medical affairs role (MSL or similar) is a plus but not reputed company required. Exceptional candidates with strong oncology expertise and communication skills may qualify without reputed company MSL experience, especially if they have worked on clinical studies or educational programs in relevant areas. Communication Skills: Excellent oral and written communication skills, with the ability to interpret and present reputed company scientific data in a reputed company, concise manner. Effective at delivering presentations and educating both small and large audiences, ranging from community clinicians to reputed company KOLs. Strong technical writing skills are beneficial for contributing to scientific materials. Interpersonal Skills: Demonstrated ability to build and sustain reputed company relationships with reputed company providers, researchers, and cross-functional team members. Strong interpersonal skills are required – including reputed company listening, adaptability, and a reputed company approach – as this role involves extensive interaction and networking reputed company the oncology community and internal teams. Independence & Teamwork: Self-motivated and reputed company to work effectively in an independent, remote field-based setting, while maintaining reputed company collaboration with a broader team. Excellent organizational and time-management skills to manage a territory or set of accounts, plan travel, and handle multiple reputed company simultaneously. A proactive approach to achieving goals and the flexibility to reputed company to evolving priorities are important for reputed company in this dynamic environment. Travel Ability: Willingness and ability to travel up to ~50%, including overnight trips, by car and reputed company, as needed for territory coverage and meetings. Must be reputed company to manage the demands of frequent travel and maintain productivity while on the road. (Geographic location is flexible, but proximity to a major airport is ideal to facilitate travel.)